Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Accept all cookies Reject all non-essential cookies

£4.5 million award for clinical research consortium to tackle the global threat of epidemic infectious diseases

The International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) has been awarded £4.5 million to accelerate clinical research to prevent illness and deaths from epidemic infectious diseases.

ISARIC – whose Global Support Centre is hosted by the University of Oxford – is a world-wide, grass-roots consortium of clinical research networks, working together on epidemic infections such as pandemic influenza, Ebola, Lassa fever, and plague.

Read more (University of Oxford website)

Similar stories

Oxford vaccine against deadly Nipah virus granted European Medicines Agency PRIME designation

Co-led by researchers at the Pandemic Sciences Institute, the Nipah virus has been granted PRIME designation. This recognises the vaccine’s potential to address the unmet medical need arising from the devastating Nipah virus disease, which can be fatal in up to 85% of cases.

Ambitious project to develop low-cost genome sequencing for pathogens

University of Oxford announces new Professorship and Centre for Global Primary Care, with support from Dr Sadok Besrour

Latin-American genetic data available securely to approved researchers worldwide

New study confirms malaria drug is safe for children and could reduce disease spread

Study shows urgent change needed to reduce deaths from malaria and meningitis in comatose African children